InvestorsHub Logo
Followers 50
Posts 3909
Boards Moderated 0
Alias Born 03/12/2011

Re: ATLnsider post# 589603

Sunday, 04/30/2023 3:52:56 AM

Sunday, April 30, 2023 3:52:56 AM

Post# of 704231
So basically in this trial we are looking at whether Keytruda (Pembrolizumab) has any added value on top of DCvax + poly-ICLC right?

GLTU
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News